Label Changes for:
Clinoril (sulindac) tablets
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2010
- ACE-Inhibitors and Angiotensin II Antagonists: Therefore, the combination should be administered with caution in patients with compromised renal function.